Aziz Nazha, MD, completed his medical education at Tishreen University in Syria and trained as a resident in internal medicine at the Thomas Jefferson University Affiliated Atlanticare Regional Medical Center. He obtained his fellowship in leukemia at The University of Texas MD Anderson Cancer Center in Houston, TX and completed a hematology and medical oncology fellowship at The Cleveland Clinic Taussig Cancer Institute.
Currently, Dr Nazha is an Assistant Professor at Lerner College of Medicine in Cleveland Clinic, Ohio. Dr Nazha holds multiple memberships including the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH) and more. He serves on the editorial board of Annals of Hematology & Oncology and other blood cancer specialized journals.
Speaking on novel strategies in treating myeloid malignancies
Dr Nazha’s research focuses on improving the management and treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other myeloid malignancies. He has been involved in risk stratification of patients for a more personalized approach in treatment.
Dr Nazha works on combining artificial intelligence (AI) in clinical practice, with the aim of improved healthcare, and he has been appointed as the Director of the new Center for Clinical Artificial Intelligence at Cleveland Clinic and as Associate Medical Director for AI.